Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.3594
Abstract: Key Points Question Is the receipt of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) associated with worse clinical outcomes among patients with COVID-19? Findings In this systematic review and meta-analysis of 52 studies… read more here.
Keywords: clinical outcomes; association renin; among patients; aceis arbs ... See more keywords
Renin-angiotensin system inhibition in COVID-19 patients
Sign Up to like & getrecommendations! Published in 2020 at "Netherlands Heart Journal"
DOI: 10.1007/s12471-020-01439-5
Abstract: Angiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‑1 receptor blockers (ARBs) are among the most widely prescribed drugs for the treatment of arterial hypertension, heart failure and chronic kidney disease. A number of studies, mainly in… read more here.
Keywords: covid patients; renin angiotensin; aceis arbs; covid ... See more keywords
The angiotensin receptor and neprilysin inhibitor, LCZ696, in heart failure: A meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030904
Abstract: Background: LCZ696 is a novel neuroendocrine inhibitor that has been widely used in heart failure (HF). However, its advantage over other neuroendocrine inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin-receptor blockers (ARBs) has not… read more here.
Keywords: heart failure; randomized controlled; controlled trials; aceis arbs ... See more keywords
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis.
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001281
Abstract: BACKGROUND Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are known to increase the expression of angiotensin converting enzyme 2 receptor, which has been shown to be the receptor for the acute severe… read more here.
Keywords: receptor; converting enzyme; aceis arbs; angiotensin converting ... See more keywords
Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v9.i1.47
Abstract: BACKGROUND Recent studies have revealed that sustained ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no harmful effects on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. AIM To investigate the… read more here.
Keywords: covid patients; angiotensin converting; aceis arbs; hypertension ... See more keywords
Influence of Renin-Angiotensin System Inhibitors on Postoperative Delirium in Patients With Pulmonary Arterial Hypertension: A Secondary Analysis of a Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.851104
Abstract: Objective To investigate the correlation between preoperative use of ACEIs/ARBs and postoperative delirium (POD) in surgical patients with pulmonary arterial hypertension (PAH). Methods The present study is a secondary analysis of a retrospective cohort study… read more here.
Keywords: pod; aceis arbs; pulmonary arterial; analysis ... See more keywords